FDA Drug Application (091614) for NAFCILLIN SODIUM by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number091614
Product Number001
FormINJECTABLE;INJECTION
DosageEQ 10GM BASE/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameNAFCILLIN SODIUM
Active IngredientNAFCILLIN SODIUM

Active IngredientCount
List of drugs with Active Ingredient NAFCILLIN SODIUM5


Back to FDA Applications sponsored by AUROBINDO PHARMA LTD